• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results

  • — 5 Sep, 2007
AudioMedica News
AudioMedica News
Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results
Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results
00:00 /
RSS Feed
Share
Link
Embed
Stefano Ghio
Stefano Ghio
Cecilia Linde
Cecilia Linde

REFERENCE: Hotline III, 3222 page 315, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
STEFANO GHIO, San Matteo University Hospital, Italy
COMMENT: CECILIA LINDE, Karolinska University Hospital, Stockholm

The standard echocardiographic criteria for selecting patients to receive cardiac resynchronisation are not adequate according to Stefano Ghio. During the ESC Congress in Vienna he presented results from the PROSPECT trial and afterwards he talked with Sarah Maxwell. Cecilia Linde gave Nicola Solomon her comments on the findings.

[audio:https://www.audiomedica.com/podcasting/cardio/070904_ghio_linde.mp3]

You may also like...

  • Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results 6 Nov, 2007
  • Audio Journal of Cardiovascular Medicine: June 2006 – In the company of Michael Petch Audio Journal of Cardiovascular Medicine: June 2006 – In the company of Michael Petch 29 May, 2006
  • Central Pressure And New Goals: Should Be Hypertension Therapy Priorities Central Pressure And New Goals: Should Be Hypertension Therapy Priorities 6 Jul, 2009
  • Drug-eluting Stents: Cost-Benefit Targeting? Drug-eluting Stents: Cost-Benefit Targeting? 12 Sep, 2005
  • Previous story Patients with High Restenosis Risk Benefit More from Drug Eluting Stents
  • Next story Drug Eluting Stents: Higher Late Mortality in STEMI Patients Than Bare Metal: GRACE Registry Findings
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per…
  • Home
  • Cardiovascular
  • Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.